TRICARE; Notice of TRICARE Plan Program Changes for Calendar Year 2021, 68312-68314 [2020-23892]
Download as PDF
68312
Federal Register / Vol. 85, No. 209 / Wednesday, October 28, 2020 / Notices
any comments addressing the 60-Day
Notice.
Burden Statement: The respondent
burden for this collection is estimated to
average 1.05 hours per response. These
estimates include the time needed to
review instructions; develop, acquire,
install, and utilize technology and
systems for the purposes of collecting,
validating, and verifying information,
processing and maintaining information
and disclosing and providing
information; adjust the existing ways to
comply with any previously applicable
instructions and requirements; train
personnel to be able to respond to a
collection of information; and transmit
or otherwise disclose the information.
Respondents/Affected Entities: 34.
Estimated number of responses: 506.
Estimated total annual burden on
respondents: 529 hours.
Frequency of collection: On occasion.
There are no capital costs or operating
and maintenance costs associated with
this collection.
(Authority: 44 U.S.C. 3501 et seq.)
Dated: October 23, 2020.
Robert Sidman,
Deputy Secretary of the Commission.
[FR Doc. 2020–23833 Filed 10–27–20; 8:45 am]
BILLING CODE 6351–01–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Defense Advisory Committee on
Women in the Services; Notice of
Federal Advisory Committee Meeting
Under Secretary of Defense for
Personnel and Readiness, Department of
Defense (DoD).
ACTION: Notice of Federal Advisory
Committee meeting.
AGENCY:
The DoD is publishing this
notice to announce that the following
Federal Advisory Committee meeting of
the Defense Advisory Committee on
Women in the Services (DACOWITS)
will take place.
DATES:
Day 1—Open to the public Tuesday,
December 8, 2020 from 8:30 a.m. to
12:00 p.m.
Day 2—Open to the public
Wednesday, December 9, 2020 from
8:30 a.m. to 12:00 p.m.
ADDRESSES: The meeting will be held by
videoconference. Participant access
information will be provided after
registering. (Pre-meeting registration is
required. See guidance in
SUPPLEMENTARY INFORMATION, ‘‘Meeting
Accessibility’’).
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:29 Oct 27, 2020
Jkt 253001
FOR FURTHER INFORMATION CONTACT:
Colonel Elaine Freeman, U.S. Army,
(703) 697–2122 (Voice), 703–614–6233
(Facsimile), roelene.e.freeman.mil@
mail.mil (Email). Mailing address is
4800 Mark Center Drive, Suite 04J25–01,
Alexandria, VA 22350. website: https://
dacowits.defense.gov. The most up-todate changes to the meeting agenda can
be found on the website.
SUPPLEMENTARY INFORMATION: This
meeting is being held under the
provisions of the Federal Advisory
Committee Act (FACA) of 1972 (5
U.S.C., Appendix, as amended), the
Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and
41 CFR 102–3.140 and 102–3.150.
Availability of Materials for the
Meeting: Additional information,
including the agenda or any updates to
the agenda, is available at the
DACOWITS website, https://
dacowits.defense.gov/. Materials
presented in the meeting may also be
obtained on the DACOWITS website.
Purpose of the Meeting: The purpose
of the meeting is for the DACOWITS to
receive written information and
briefings on topics related to the
recruitment, retention, employment,
integration, well-being, and treatment of
women in the Armed Forces of the
United States.
Agenda: Tuesday, December 8, 2020,
from 8:30 a.m. to 12:00 p.m.—Welcome,
Introductions, and Announcements;
Request for Information Status Update;
and Briefings and DACOWITS
discussion. Wednesday, December 9,
2020, from 8:30 a.m. to 12:00 p.m.—
Welcome, Introductions, and
Announcements; and Briefings and
DACOWITS discussion.
Meeting Accessibility: Pursuant to 5
U.S.C. 552b and 41 CFR 102–3.140
through 102–3.165, this meeting is open
to the public from 8:30 a.m. to 12:00
p.m. on December 8, 2020 and 8:30 a.m.
to 12:00 p.m. on December 9, 2020. The
meeting will be held by
videoconference. The number of
participants is limited and is on a firstcome basis. All members of the public
who wish to participate must register by
contacting DACOWITS at
osd.pentagon.ousd-p-r.mbx.dacowits@
mail.mil or by contacting Mr. Robert
Bowling at (703) 380–0116 no later than
Monday, November 30, 2020. Once
registered, the web address and/or audio
number will be provided.
Special Accommodations: Individuals
requiring special accommodations to
access the public meeting should
contact Mr. Robert Bowling no later
than Monday, November 30, 2020 so
that appropriate arrangements can be
made.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Written Statements: Pursuant to 41
CFR 102–3.140, and section 10(a)(3) of
the FACA, interested persons may
submit a written statement to the
DACOWITS. Individuals submitting a
written statement must submit their
statement no later than 5:00 p.m.,
Monday, November 30, 2020 to Mr.
Robert Bowling (703) 380–0116 (voice)
or to osd.pentagon.ousd-pr.mbx.dacowits@mail.mil (email). If a
statement is not received by Monday,
November 30, 2020, prior to the
meeting, which is the subject of this
notice, then it may not be provided to
or considered by the Committee during
this quarterly business meeting. The
Designated Federal Officer will review
all timely submissions with the
DACOWITS Chair and ensure they are
provided to the members of the
Committee.
Dated: October 23, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2020–23877 Filed 10–27–20; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
TRICARE; Notice of TRICARE Plan
Program Changes for Calendar Year
2021
Office of the Secretary of
Defense, Department of Defense (DoD).
ACTION: Notice.
AGENCY:
This notice provides a
notification of TRICARE Plan program
changes for calendar year 2021. Changes
or improvements to the TRICARE
program benefits are provided in the
supplementary information section.
DATES: TRICARE health plan
information in this notice is valid for
services during calendar year 2021
(January 1, 2021–December 31, 2021).
ADDRESSES: Defense Health Agency,
TRICARE Health Plan, 7700 Arlington
Boulevard, Suite 5101, Falls Church,
Virginia 22042–5101.
FOR FURTHER INFORMATION CONTACT: Mr.
Mark A. Ellis, (703) 681–0039.
SUPPLEMENTARY INFORMATION: An
interim final rule published in the
Federal Register (FR) on September 29,
2017 (82 FR 45438–45461) established
the requirement for the Director,
Defense Health Agency, to provide a
public notice to TRICARE program
beneficiaries with a summary of changes
to the TRICARE program each calendar
year in connection with the open season
enrollment period.
SUMMARY:
E:\FR\FM\28OCN1.SGM
28OCN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 209 / Wednesday, October 28, 2020 / Notices
The following changes or
improvements to the TRICARE program
benefits apply for calendar year 2021:
• Improving what’s covered:
Coronavirus Disease 2019 (COVID–19)
Response:
➢ The following three temporary
changes were made effective May 12,
2020, for care and treatment within the
United States (US) and effective March
10, 2020, for the TRICARE Overseas
Program: Temporary audio-only
telephonic office visits; temporary
waiver of cost-shares, co-pays and
deductibles for all covered in-network
telehealth services (for Prime and Select
beneficiaries); and temporary interstate
and international licensing. These
changes will expire when the President
of the US declares the national
emergency is terminated. Overseas
termination date may vary from the US
date and will be determined by the
Assistant Secretary of Defense for
Health Affairs.
➢ Flexibility was added for
reinstatement of coverage for TRICARE
Reserve Select (TRS) by expanding the
three-month window to reinstate
coverage for a beneficiary due to a lapse
in coverage to a five-month window.
This is in effect until the termination of
the state of national emergency.
Screenings:
➢ Effective January 1, 2020, Digital
Breast Tomosynthesis (DBT) for Breast
Cancer (BC) Screening is covered under
the Provisional Coverage Program. This
three-dimensional mammography DBT
for BC screening may be covered
annually instead of conventional twodimensional screening mammography.
It is covered for all women beginning at
age 40 and covered annually beginning
at age 30 for women who have a 15
percent or greater lifetime risk of breast
cancer. No pre-authorization is required.
➢ Effective December 2, 2019, and
covered under the TRICARE Basic
Program, this change allows for the
separate reimbursement of instrumentbased vision screening for children age
one to age six when provided by a
physician other than an ophthalmologist
or optometrist as part of a regular
preventive office visit under the wellchild care program. No preauthorization is required.
Mental Health:
➢ The Autism Care Demonstration is
focused on ensuring TRICARE
beneficiaries diagnosed with autism
spectrum disorder (ASD) and their
families receive high-value care and
services that will help them reach their
maximum potential. During the COVID–
19 period, DHA has authorized the
temporary use of unlimited applied
behavior analysis parent/training
VerDate Sep<11>2014
18:29 Oct 27, 2020
Jkt 253001
guidance (Current Procedural
Terminology Code 97156) only via
telehealth to ensure Military children
diagnosed with ASD and their families
continue to receive support during the
crisis. This exception to policy allows
parents to maintain elements of the
treatment plan during the crisis, which
has in many cases made provision of inperson services impossible or unsafe.
➢ Effective March 5, 2019, but
implemented in 2020, SpravatoTM is
covered under the Basic Medical
Program for treatment-resistant
depression. This drug is administered
intra-nasally under the supervision of a
TRICARE-authorized provider during an
office visit. Pre-authorization under the
medical benefit is required. Off-label
use of Spravato is excluded.
Demonstrations, Programs & Pilots:
➢ The existing Laboratory Developed
Test (LDT) demonstration ensuring
beneficiaries continue to have access to
safe and effective non-FDA approved
LDTs has been extended for an
additional three years. Additionally,
TRICARE Overseas Program (TOP)
beneficiaries may now receive tests
covered under the LDT demonstration
from either Clinical Laboratory
Improvement Amendments of 1988certified laboratories or laboratories
otherwise approved by the TOP
contractor in conjunction with specific
government-directed standards.
➢ Effective January 1, 2020, TRICARE
implemented a three-year Home Health
Value-Based Purchasing demonstration
designed to improve the quality and
delivery of home health services by
rewarding providers with incentive
payments that give higher quality and
more efficient care. This demonstration
applies to home health agencies that
provide services in the following nine
states: Arizona, Florida, Iowa,
Maryland, Massachusetts, Nebraska,
North Carolina, Tennessee, and
Washington.
➢ Launched on May 1, 2020, the
TRICARE Select Navigator Program
provides a health care assistance service
to certain covered beneficiaries enrolled
in TRICARE Select using purchased care
to improve health outcomes and patient
experience for covered beneficiaries
with complex medical conditions.
➢ Humana Military continues to
partner with Kaiser Permanente to offer
care and coverage to TRICARE Prime
eligible beneficiaries in the Atlanta,
Georgia area through the TRICARE
Accountable Care Pilot. The pilot began
on January 1, 2020, and will continue
through 2022.
Other Significant Changes:
➢ Effective January 1, 2020, and
covered under the TRICARE Basic
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
68313
Medical Program, Continuous Glucose
Monitor Systems (CGMS) are now
covered for Type 2 diabetes in addition
to Type 1 diabetes. Smart phones and
watches used in conjunction with
CGMS are not covered.
➢ Effective November 21, 2019, and
covered under the TRICARE Basic
Medical Program, this benefit
enhancement adds coverage for nonimplantable bone conducting hearing
devices for infants and toddlers who are
too young (typically age 5 and younger)
for implants. These devices are
considered a prosthetic bridge to
transplantation for patient whose skull
development will not yet support an
implant, and are also covered as
prosthetic devices for Active Duty
Family Members who meet criteria for
hearing aid coverage. No
preauthorization is required.
➢ Effective April 16, 2020, TRICARE
reimburses for care provided by
Physical Therapist Assistants (PTAs)
and Occupational Therapist Assistants
(OTAs) who are supervised by physical
therapists and occupational therapists,
increasing the provider pool available to
care for TRICARE beneficiaries.
➢ A Move Away From Lower-ValueCare Interventions: (1) Vitamin D
Screening for otherwise healthy/
asymptomatic individuals is excluded
as the screening has no impact on health
outcomes. (2) Transcutaneous Electrical
Nerve Stimulators are excluded for
acute, subacute and chronic low back
pain because there is increasing
evidence that this treatment is not
effective.
• Out-of-Pocket Costs:
Certain beneficiary out-of-pocket costs
(enrollment fees, premiums,
catastrophic caps, deductibles, and
copayments) are annually adjusted
based on federal law and regulations,
most notably by the annual retiree cost
of living adjustment, or Cost of Living
Adjustment (COLA). Currently there is a
difference in copayments between those
who joined the military before January
1, 2018, (Group A), and those who
joined after that date (Group B). The
retiree COLA will not be announced
until mid-October 2020. As of August
31, 2020, the projected COLA increase
is 1.3 percent. Beneficiary out-of-pocket
expenses impacted by the 2020 COLA
will be posted to the tricare.mil/changes
web page before the start of TRICARE
Open Season.
Pharmacy Out-of-Pocket Expenses for
CY 2021 remain the same. See table
below for TRICARE Pharmacy out-ofpocket expenses that take effect on
January 1, 2021.
E:\FR\FM\28OCN1.SGM
28OCN1
68314
Federal Register / Vol. 85, No. 209 / Wednesday, October 28, 2020 / Notices
TABLE 1—PHARMACY COPAYMENTS FOR CALENDAR YEAR 2021
Year
Copayment amount
for a 30-day supply of
a retail generic is:
Copayment amount
for a 30-day supply of
a retail formulary is:
Copayment amount
for a 90-day supply of
a mail order generic
is:
Copayment amount
for a 90-day supply of
a mail order formulary
is:
Copayment amount
for a 90-day supply of
a mail order
non-formulary
is:
2021 .........................
$13
$33
$10
$29
$60
• For more information, visit
tricare.mil/changes or call your regional
TRICARE contractor.
Dated: October 22, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2020–23892 Filed 10–27–20; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Notice of Availability of Draft
Environmental Impact Statement For
the Long Range Discrimination Radar
Operations at Clear Air Force Station,
Alaska
Missile Defense Agency,
Department of Defense.
ACTION: Notice of availability.
AGENCY:
The Missile Defense Agency
(MDA), as the lead agency, announces
the availability of the Draft
Environmental Impact Statement (EIS)
to evaluate the potential environmental
impacts associated with proposed
changes in operational concept and
other associated activities for the Long
Range Discrimination Radar (LRDR)
located at Clear Air Force Station
(CAFS), Alaska. The Federal Aviation
Administration (FAA) and the
Department of the Air Force (DAF) are
cooperating agencies to this Draft EIS.
The Draft EIS was prepared in
accordance with the National
Environmental Policy Act (NEPA) of
1969; the Council on Environmental
Quality Regulations for Implementing
the Procedural Provisions of NEPA;
MDA’s NEPA Implementing Procedures;
DAF Environmental Impact Analysis
Process; and FAA’s NEPA Policies and
Procedures. The Draft EIS also supports
compliance with the National Historic
Preservation Act of 1966 and its
implementing regulations.
DATES: The 52-day public comment
period will be from October 30, 2020 to
December 21, 2020. All public
comments are requested by December
21, 2020. Due to recent federal and state
guidance on public gatherings, MDA
will hold an Online Open House and
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:29 Oct 27, 2020
Jkt 253001
Telephone Public Meeting, in place of
in-person public meetings. Notification
for public involvement will be
published and announced in local news
media to encourage public participation
and review.
ADDRESSES: Comments may be
submitted by:
• Email: lrdr.info@mda.mil.
• Voicemail: 256–450–1599.
• Fax: 907–644–2022.
• Mail: LRDR CAFS EIS C/O HDR
2525 C Street, Suite 500, Anchorage, AK
99503.
All comments received during the 52day public comment period will become
part of the public record and considered
in the Final EIS.
FOR FURTHER INFORMATION CONTACT: Mr.
Ryan Keith, MDA Public Affairs, at 256–
450–1599 or by email: lrdr.info@
mda.mil.
SUPPLEMENTARY INFORMATION:
Proposed Action and Alternative: In
response to the Congressional mandate
to deploy the LRDR, MDA completed a
siting analysis for the LRDR, which
selected CAFS out of 50 candidate
Department of Defense installations in
Alaska. In June 2016, MDA and DAF
prepared an Environmental Assessment
(EA), to evaluate the potential
environmental impacts associated with
the construction and operation of the
LRDR at CAFS. The 2016 EA resulted in
a Finding of No Significant Impact, and
construction of the LRDR began in July
2017. Since that time, due to emerging
threats, the MDA proposes to modify the
LRDR operational requirements and
procedures to reflect continuous
operations. Due to the proposed changes
to LRDR operations, airspace
restrictions at CAFS are necessary to
ensure that aircraft would not encounter
high intensity radiation fields (HIRF)
resulting from the LRDR operations that
exceed FAA’s HIRF certification
standards for aircraft electrical and
electronic systems. The proposed
airspace restrictions include expanding
the existing Restricted Area (R–2206) at
CAFS by adding six new Restricted
Areas.
MDA has considered two alternatives
to the Proposed Action: The No Action
Alternative and the two-tier alternative.
Under the No Action Alternative, the
PO 00000
Frm 00030
Fmt 4703
Sfmt 9990
LRDR would be operated in a manner
that would contain HIRF within existing
R–2206 such that no new actions would
need to be taken to limit aircraft flight.
Under the two-tier alternative, the
existing R–2206 would be expanded
with two new Restricted Areas. The
two-tier alternative was presented
during the scoping process, but was
eliminated from further analysis in
order to minimize potential impacts on
airspace.
The environmental analysis in the
Draft EIS addresses the following
environmental resource areas: Airspace
management; air quality; biological
resources; climate; hazardous materials;
solid waste and pollution prevention;
historical, architectural, archaeological,
and cultural resources; land use; natural
resources and energy supply; noise and
compatible land use; safety;
socioeconomics and environmental
justice; subsistence; visual effects; and
water resources.
This Draft EIS supports the FAA
rulemaking process related to the
Restricted Areas.
Comments Invited: MDA invites all
interested members of the public, as
well as federal, state, tribal and local
agencies, to comment on the Proposed
Action and to participate in the Online
Open House and the Telephone Public
Meeting in review of the Draft EIS.
Through these public involvement
opportunities, attendees can learn about
findings in the Draft EIS and may
provide verbal and written comments.
For more information, including a
downloadable copy of the Draft EIS,
visit the MDA’s website at https://
www.mda.mil/system/lrdr.
Dated: October 23, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2020–23889 Filed 10–27–20; 8:45 am]
BILLING CODE 5001–06–P
E:\FR\FM\28OCN1.SGM
28OCN1
Agencies
[Federal Register Volume 85, Number 209 (Wednesday, October 28, 2020)]
[Notices]
[Pages 68312-68314]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23892]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
TRICARE; Notice of TRICARE Plan Program Changes for Calendar Year
2021
AGENCY: Office of the Secretary of Defense, Department of Defense
(DoD).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice provides a notification of TRICARE Plan program
changes for calendar year 2021. Changes or improvements to the TRICARE
program benefits are provided in the supplementary information section.
DATES: TRICARE health plan information in this notice is valid for
services during calendar year 2021 (January 1, 2021-December 31, 2021).
ADDRESSES: Defense Health Agency, TRICARE Health Plan, 7700 Arlington
Boulevard, Suite 5101, Falls Church, Virginia 22042-5101.
FOR FURTHER INFORMATION CONTACT: Mr. Mark A. Ellis, (703) 681-0039.
SUPPLEMENTARY INFORMATION: An interim final rule published in the
Federal Register (FR) on September 29, 2017 (82 FR 45438-45461)
established the requirement for the Director, Defense Health Agency, to
provide a public notice to TRICARE program beneficiaries with a summary
of changes to the TRICARE program each calendar year in connection with
the open season enrollment period.
[[Page 68313]]
The following changes or improvements to the TRICARE program
benefits apply for calendar year 2021:
Improving what's covered:
Coronavirus Disease 2019 (COVID-19) Response:
[rtarr8] The following three temporary changes were made effective
May 12, 2020, for care and treatment within the United States (US) and
effective March 10, 2020, for the TRICARE Overseas Program: Temporary
audio-only telephonic office visits; temporary waiver of cost-shares,
co-pays and deductibles for all covered in-network telehealth services
(for Prime and Select beneficiaries); and temporary interstate and
international licensing. These changes will expire when the President
of the US declares the national emergency is terminated. Overseas
termination date may vary from the US date and will be determined by
the Assistant Secretary of Defense for Health Affairs.
[rtarr8] Flexibility was added for reinstatement of coverage for
TRICARE Reserve Select (TRS) by expanding the three-month window to
reinstate coverage for a beneficiary due to a lapse in coverage to a
five-month window. This is in effect until the termination of the state
of national emergency.
Screenings:
[rtarr8] Effective January 1, 2020, Digital Breast Tomosynthesis
(DBT) for Breast Cancer (BC) Screening is covered under the Provisional
Coverage Program. This three-dimensional mammography DBT for BC
screening may be covered annually instead of conventional two-
dimensional screening mammography. It is covered for all women
beginning at age 40 and covered annually beginning at age 30 for women
who have a 15 percent or greater lifetime risk of breast cancer. No
pre-authorization is required.
[rtarr8] Effective December 2, 2019, and covered under the TRICARE
Basic Program, this change allows for the separate reimbursement of
instrument-based vision screening for children age one to age six when
provided by a physician other than an ophthalmologist or optometrist as
part of a regular preventive office visit under the well-child care
program. No pre-authorization is required.
Mental Health:
[rtarr8] The Autism Care Demonstration is focused on ensuring
TRICARE beneficiaries diagnosed with autism spectrum disorder (ASD) and
their families receive high-value care and services that will help them
reach their maximum potential. During the COVID-19 period, DHA has
authorized the temporary use of unlimited applied behavior analysis
parent/training guidance (Current Procedural Terminology Code 97156)
only via telehealth to ensure Military children diagnosed with ASD and
their families continue to receive support during the crisis. This
exception to policy allows parents to maintain elements of the
treatment plan during the crisis, which has in many cases made
provision of in- person services impossible or unsafe.
[rtarr8] Effective March 5, 2019, but implemented in 2020,
SpravatoTM is covered under the Basic Medical Program for treatment-
resistant depression. This drug is administered intra-nasally under the
supervision of a TRICARE-authorized provider during an office visit.
Pre-authorization under the medical benefit is required. Off-label use
of Spravato is excluded.
Demonstrations, Programs & Pilots:
[rtarr8] The existing Laboratory Developed Test (LDT) demonstration
ensuring beneficiaries continue to have access to safe and effective
non-FDA approved LDTs has been extended for an additional three years.
Additionally, TRICARE Overseas Program (TOP) beneficiaries may now
receive tests covered under the LDT demonstration from either Clinical
Laboratory Improvement Amendments of 1988-certified laboratories or
laboratories otherwise approved by the TOP contractor in conjunction
with specific government-directed standards.
[rtarr8] Effective January 1, 2020, TRICARE implemented a three-
year Home Health Value-Based Purchasing demonstration designed to
improve the quality and delivery of home health services by rewarding
providers with incentive payments that give higher quality and more
efficient care. This demonstration applies to home health agencies that
provide services in the following nine states: Arizona, Florida, Iowa,
Maryland, Massachusetts, Nebraska, North Carolina, Tennessee, and
Washington.
[rtarr8] Launched on May 1, 2020, the TRICARE Select Navigator
Program provides a health care assistance service to certain covered
beneficiaries enrolled in TRICARE Select using purchased care to
improve health outcomes and patient experience for covered
beneficiaries with complex medical conditions.
[rtarr8] Humana Military continues to partner with Kaiser
Permanente to offer care and coverage to TRICARE Prime eligible
beneficiaries in the Atlanta, Georgia area through the TRICARE
Accountable Care Pilot. The pilot began on January 1, 2020, and will
continue through 2022.
Other Significant Changes:
[rtarr8] Effective January 1, 2020, and covered under the TRICARE
Basic Medical Program, Continuous Glucose Monitor Systems (CGMS) are
now covered for Type 2 diabetes in addition to Type 1 diabetes. Smart
phones and watches used in conjunction with CGMS are not covered.
[rtarr8] Effective November 21, 2019, and covered under the TRICARE
Basic Medical Program, this benefit enhancement adds coverage for non-
implantable bone conducting hearing devices for infants and toddlers
who are too young (typically age 5 and younger) for implants. These
devices are considered a prosthetic bridge to transplantation for
patient whose skull development will not yet support an implant, and
are also covered as prosthetic devices for Active Duty Family Members
who meet criteria for hearing aid coverage. No preauthorization is
required.
[rtarr8] Effective April 16, 2020, TRICARE reimburses for care
provided by Physical Therapist Assistants (PTAs) and Occupational
Therapist Assistants (OTAs) who are supervised by physical therapists
and occupational therapists, increasing the provider pool available to
care for TRICARE beneficiaries.
[rtarr8] A Move Away From Lower-Value-Care Interventions: (1)
Vitamin D Screening for otherwise healthy/asymptomatic individuals is
excluded as the screening has no impact on health outcomes. (2)
Transcutaneous Electrical Nerve Stimulators are excluded for acute,
subacute and chronic low back pain because there is increasing evidence
that this treatment is not effective.
Out-of-Pocket Costs:
Certain beneficiary out-of-pocket costs (enrollment fees, premiums,
catastrophic caps, deductibles, and copayments) are annually adjusted
based on federal law and regulations, most notably by the annual
retiree cost of living adjustment, or Cost of Living Adjustment (COLA).
Currently there is a difference in copayments between those who joined
the military before January 1, 2018, (Group A), and those who joined
after that date (Group B). The retiree COLA will not be announced until
mid-October 2020. As of August 31, 2020, the projected COLA increase is
1.3 percent. Beneficiary out-of-pocket expenses impacted by the 2020
COLA will be posted to the tricare.mil/changes web page before the
start of TRICARE Open Season.
Pharmacy Out-of-Pocket Expenses for CY 2021 remain the same. See
table below for TRICARE Pharmacy out-of-pocket expenses that take
effect on January 1, 2021.
[[Page 68314]]
Table 1--Pharmacy Copayments for Calendar Year 2021
--------------------------------------------------------------------------------------------------------------------------------------------------------
Copayment amount for Copayment amount for Copayment amount for
Copayment amount for Copayment amount for a 90-day supply of a a 90-day supply of a a 90-day supply of a
Year a 30-day supply of a a 30-day supply of a mail order generic mail order formulary mail order non-
retail generic is: retail formulary is: is: is: formulary is:
--------------------------------------------------------------------------------------------------------------------------------------------------------
2021................................. $13 $33 $10 $29 $60
--------------------------------------------------------------------------------------------------------------------------------------------------------
For more information, visit tricare.mil/changes or call
your regional TRICARE contractor.
Dated: October 22, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2020-23892 Filed 10-27-20; 8:45 am]
BILLING CODE 5001-06-P